Quantcast

Latest biopharmaceuticals Stories

2014-07-21 08:27:28

LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Editionhttps://www.reportbuyer.com/product/2076279/The-World-Market-for-Biosimlars-EPO-G-CSF-HGH-Insulin-Interferon-Alpha-Monoclonal-Antibodies-Other-4th-Edition.html This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs,...

2014-07-15 12:29:09

BETHLEHEM, Pa., July 15, 2014 /PRNewswire/ -- Particle Sciences, Inc. has expanded its development capabilities to accommodate the increasing demand for biopharmaceutical formulation and analysis. According to Robert Becker, Vice President Biopharmaceutical Sales and Business Development at Particle Sciences, "Our company has been working with biologics for some time, accumulating significant infrastructure and intellectual property. We regularly work with biopharmaceuticals and...

2014-06-24 12:28:27

LAUSANNE, Switzerland and KOLKATA, India, June 24, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs, including anti-bacterial, oncology as well as companion diagnostics, and TCG Lifesciences Limited (TCGLS) a leading contract research services company in the area of early drug discovery and development, today announced that they have...

2014-05-28 08:31:42

LAUSANNE, Switzerland, May 28, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced that new data on the investigational compounds Debio 1143 (SMAC mimetic), Debio 1347/CH5183284 (FGFR 1,2,3 inhibitor), and Debio 0932 (Hsp90 inhibitor) will be presented at the 50th American Society of Clinical Oncology (ASCO) Annual...

2014-05-28 04:24:21

LONDON and TORONTO, May 28, 2014 /PRNewswire/ -- ThioBridge(TM) linker to attach cytotoxic payloads to alpha fetoprotein PolyTherics Limited ("PolyTherics"), an Abzena company that provides technologies and services to enable the development of better biopharmaceuticals, today announced a collaboration with Alpha Cancer Technologies Inc. ("ACT"), a Canadian company with a targeted drug delivery platform based on alpha fetoprotein ("AFP"). PolyTherics will produce...

2014-05-27 04:21:40

SINGAPORE and LAUSANNE, Switzerland, May 27, 2014 /PRNewswire/ -- Orient EuroPharma Co., Ltd. (Orient EuroPharma) a specialty pharmaceutical company focused in marketing and commercialization with subsidiaries across Hong Kong, Malaysia, Singapore, Philippines with a strong sales network of 360 dedicated and experienced sales representatives and Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet...

2014-05-23 04:20:53

LONDON, May 23, 2014 /PRNewswire/ -- New Company Created to be a Leading Provider of Technologies and Services to Enable Better Biopharmaceuticals - PolyTherics and Antitope to continue to trade as wholly owned subsidiaries of Abzena - New brand highlights depth and range of offering to the global biopharmaceutical industry - Abzena to establish headquarters in Cambridge, UK PolyTherics Limited ("PolyTherics"), a...

2014-05-15 08:31:47

LONDON, May 15, 2014 /PRNewswire/ -- Provectus Biopharmaceuticals (PVCT) was the big percentage gainer in the markets today with the stock enjoying its last day trading over the counter before it moves to higher ground. Shares were higher by 25.3% as traders anticipated the stock being a good long term bet due to recent positive trial results and a stock up listing to trade on Nasdaq. The volume was heavier than normal with more than $8 million exchanging hands in a busy days...

2014-05-09 16:24:06

DUBLIN, May 9, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/v7jvhk/stability_testing) has announced the addition of the "Stability Testing of Pharmaceuticals and Biopharmaceuticals - Including Practical Workshops (Seminar, London)" conference to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The Stability Testing of Pharmaceuticals and Biopharmaceuticals seminar will take place on 02-03 July 2014 at The Rembrandt Hotel, London...

2014-05-06 16:28:42

LONDON, May 6, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Cell Culture: The Market for Media, Sera and Reagents, 5th Edition http://www.reportbuyer.com/pharma_healthcare/diagnostics/cell_culture_market_media_sera_reagents_5th_edition.htmlThe growth in biopharmaceuticals is creating an unprecedented increase in demand for cell culture products. Cell culture techniques have been used in biological sciences for more than 50 years; however, cell culture...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related